Complement is dysregulated in Huntington’s disease in mouse and man

Jacqui Nimmo(UK Dementia Research Institute), Wioleta M. Zelek(UK Dementia Research Institute), Kyle Fears(UK Dementia Research Institute), Paul Morgan(Cardiff University), Thomas H. Massey(UK Dementia Research Institute), K. Y. Lee(UK Dementia Research Institute)
Immunobiology
July 1, 2025
10.1016/j.imbio.2025.153034
Cited by 1

Related Papers

CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
|Cell|2019|558
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
|Alzheimer s Research & Therapy|2020|48
The complement system in neurodegenerative diseases
|Clinical Science|2024|48
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy
|International Journal of Molecular Sciences|2020|47
Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials
|Frontiers in Neuroscience|2021|40